CRISPR-Cas9 Gene Editing Shows Very Low Risk of Mistakes
Ann and Robert H. Lurie Children's Hospital of ChicagoAlong with the promise that CRISPR-Cas9 gene editing technology can offer new human therapies is the need to ensure its safety. A recent study showed that CRISPR-Cas9 did not produce off-target gene mutations in zebrafish. These results, published in Frontiers in Genetics, confirm previous data in animal models that the risk to the rest of the genome from gene editing is minimal.